Wai Yuen Tong Medicine Holdings (HKSE:00897) EBITDA Margin % : 14.17% (As of Sep. 2023)

Wai Yuen Tong Medicine Holdings EBITDA Margin % Chart

Wai Yuen Tong Medicine Holdings Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EBITDA Margin %		Get a 7-Day Free Trial					21.50	99.98	-9.27	11.23	16.12

Wai Yuen Tong Medicine Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EBITDA Margin %	Get a 7-Day Free Trial															15.57	-7.31	5.51	8.96	14.17

Competitive Comparison of Wai Yuen Tong Medicine Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wai Yuen Tong Medicine Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's EBITDA Margin % falls into.

Wai Yuen Tong Medicine Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Wai Yuen Tong Medicine Holdings's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

Wai Yuen Tong Medicine Holdings's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wai Yuen Tong Medicine Holdings  (HKSE:00897) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Wai Yuen Tong Medicine Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description